Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 4, 2008, Pages 259-270

  Golden, Teresa ^a   Aragon, Ileana V ^a   Rutland, Beth ^b   Tucker, J Allan ^b   Shevde, Lalita A ^a   Samant, Rajeev S ^a   Zhou, Guofei ^a   Amable, Lauren ^a   Skarra, Danalea ^a   Honkanen, Richard E ^a,c  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Adriamycin; Cancer; MCF 7 cells; Oxidative stress; Phosphatase; PP5; UVC; Vinblastine

Indexed keywords

DOXORUBICIN; PACLITAXEL; PHOSPHATASE; RAPAMYCIN; SERINE THREONINE PROTEIN PHOSPHATASE 5; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CANCER TISSUE; CARCINOMA IN SITU; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL STRAIN MCF 7; CONTROLLED STUDY; DUCTAL CARCINOMA IN SITU; ENZYME SUBSTRATE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; METASTASIS; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE MICROARRAY; TUMOR XENOGRAFT; ULTRAVIOLET C RADIATION; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL DEATH; CELL LINE, TUMOR; DOXORUBICIN; HUMANS; MICE; MICE, NUDE; NUCLEAR PROTEINS; OXIDATIVE STRESS; PHOSPHOPROTEIN PHOSPHATASES; THREONINE; TIME FACTORS; ULTRAVIOLET RAYS; UP-REGULATION; VINBLASTINE;

EID: 40849126557     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.01.004     Document Type: Article

References (46)

1. Cohen P. The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. Eur. J. Biochem. 268 (2001) 5001-5010
2. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
3. Cohen P.T. Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem. Sci. 22 (1997) 245-251
4. Gallego M., and Virshup D.M. Protein serine/threonine phosphatases: life, death, and sleeping. Curr. Opin. Cell Biol. 17 (2005) 197-202
5. Honkanen R.E., and Golden T. Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?. Curr. Med. Chem. 9 (2002) 2055-2075
6. Shenolikar S., and Nairn A.C. Protein phosphatases: recent progress. Adv. Second Messenger Phosphoprot. Res. 23 (1991) 1-121
7. Chen M.S., Silverstein A.M., Pratt W.B., and Chinkers M. The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant. J. Biol. Chem. 271 (1996) 32315-32320
8. Silverstein A.M., Galigniana M.D., Chen M.S., Owens-Grillo J.K., Chinkers M., and Pratt W.B. Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin. J. Biol. Chem. 272 (1997) 16224-16230
9. Davies T.H., Ning Y.M., and Sanchez E.R. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry 44 (2005) 2030-2038
10. Zuo Z., Dean N.M., and Honkanen R.E. Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest. J. Biol. Chem. 273 (1998) 12250-12258
11. Zuo Z., Urban G., Scammell J.G., Dean N.M., McLean T.K., Aragon I., and Honkanen R.E. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry 38 (1999) 8849-8857
12. Urban G., Golden T., Aragon I.V., Cowsert L., Cooper S.R., Dean N.M., and Honkanen R.E. Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression. J. Biol. Chem. 278 (2003) 9747-9753
13. Morita K., Saitoh M., Tobiume K., Matsuura H., Enomoto S., Nishitoh H., and Ichijo H. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 20 (2001) 6028-6036
14. Zhou G., Golden T., Aragon I.V., and Honkanen R.E. Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade. J. Biol. Chem. 279 (2004) 46595-46605
15. Matsuzawa A., Nishitoh H., Tobiume K., Takeda K., and Ichijo H. Physiological roles of ASK1-mediated signal transduction in oxidative stress- and endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice. Antioxid. Redox Signal. 4 (2002) 415-425
16. Wechsler T., Chen B.P., Harper R., Morotomi-Yano K., Huang B.C., Meek K., Cleaver J.E., Chen D.J., and Wabl M. DNA-PKcs function regulated specifically by protein phosphatase 5. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1247-1252
17. Ali A., Zhang J., Bao S., Liu I., Otterness D., Dean N.M., Abraham R.T., and Wang X.F. Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes Dev. 18 (2004) 249-254
18. Zhang J., Bao S., Furumai R., Kucera K.S., Ali A., Dean N.M., and Wang X.F. Protein phosphatase 5 is required for ATR-mediated checkpoint activation. Mol. Cell. Biol. 25 (2005) 9910-9919
19. Shah B.H., and Catt K.J. Protein phosphatase 5 as a negative key regulator of Raf-1 activation. Trends Endocrinol. Metab. 17 (2006) 382-384
20. von Kriegsheim A., Pitt A., Grindlay G.J., Kolch W., and Dhillon A.S. Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5. Nat. Cell Biol. 8 (2006) 1011-1016
21. Urban G., Golden T., Aragon I.V., Scammell J.G., Dean N.M., and Honkanen R.E. Identification of an estrogen-inducible phosphatase (PP5) that converts MCF-7 human breast carcinoma cells into an estrogen-independent phenotype when expressed constitutively. J. Biol. Chem. 276 (2001) 27638-27646
22. Golden T., Aragon I.V., Zhou G., Cooper S.R., Dean N.M., and Honkanen R.E. Constitutive over expression of serine/threonine protein phosphatase 5 (PP5) augments estrogen-dependent tumor growth in mice. Cancer Lett. 215 (2004) 95-100
23. Bos R., Zhong H., Hanrahan C.F., Mommers E.C., Semenza G.L., Pinedo H.M., Abeloff M.D., Simons J.W., van Diest P.J., and van der Wall E. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 93 (2001) 309-314
24. Bos R., van der Groep P., Greijer A.E., Shvarts A., Meijer S., Pinedo H.M., Semenza G.L., van Diest P.J., and van der Wall E. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node-negative breast carcinoma. Cancer 97 (2003) 1573-1581
25. Samant R.S., Seraj M.J., Saunders M.M., Sakamaki T.S., Shevde L.A., Harms J.F., Leonard T.O., Goldberg S.F., Budgeon L., Meehan W.J., Winter C.R., Christensen N.D., Verderame M.F., Donahue H.J., and Welch D.R. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin. Exp. Metastasis 18 (2000) 683-693
26. Swingle M.R., Honkanen R.E., and Ciszak E.M. Structural basis for the catalytic activity of human serine/threonine protein phosphatase-5. J. Biol. Chem. 279 (2004) 33992-33999
27. Cliff M.J., Harris R., Barford D., Ladbury J.E., and Williams M.A. Conformational diversity in the TPR domain-mediated interaction of protein phosphatase 5 with Hsp90. Structure 14 (2006) 415-426
28. Yang J., Roe S.M., Cliff M.J., Williams M.A., Ladbury J.E., Cohen P.T., and Barford D. Molecular basis for TPR domain-mediated regulation of protein phosphatase 5. EMBO J. 24 (2005) 1-10
29. Das A.K., Cohen P.W., and Barford D. The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions. EMBO J. 17 (1998) 1192-1199
30. Chinkers M. Protein phosphatase 5 in signal transduction. Trends Endocrinol. Metab. 12 (2001) 28-32
31. Lee S.B., Bae I.H., Bae Y.S., and Um H.D. Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J. Biol. Chem. 281 (2006) 36228-36235
32. Scherz-Shouval R., Shvets E., Fass E., Shorer H., Gil L., and Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26 (2007) 1749-1760
33. Ferguson H.A., Marietta P.M., and Van Den Berg C.L. UV-induced apoptosis is mediated independent of caspase-9 in MCF-7 cells: a model for cytochrome c resistance. J. Biol. Chem. 278 (2003) 45793-45800
34. Burton L.L., Lazo J.S., and Parker K.L. Goodman and Gilman's The Pharmacological Basis of Therapeutics (2006), McGraw-Hill 1358-1360
35. Tang J.J., Shen C., and Lu Y.J. Requirement for pre-existing of p21 to prevent doxorubicin-induced apoptosis through inhibition of caspase-3 activation. Mol. Cell. Biochem. 291 (2006) 139-144
36. Bar-On O., Shapira M., and Hershko D.D. Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells. Anticancer Drugs 18 (2007) 1113-1121
37. Shirato H., Shima H., Nakagama H., Fukuda H., Watanabe Y., Ogawa K., Matsuda Y., and Kikuchi K. Expression in hepatomas and chromosomal localization of rat protein phosphatase 5 gene. Int. J. Oncol. 17 (2000) 909-912
38. Jeong J.Y., Johns J., Sinclair C., Park J.M., and Rossie S. Characterization of Saccharomyces cerevisiae protein Ser/Thr phosphatase T1 and comparison to its mammalian homolog PP5. BMC Cell Biol. 4 (2003) 3
39. Ghobrial I.M., McCormick D.J., Kaufmann S.H., Leontovich A.A., Loegering D.A., Dai N.T., Krajnik K.L., Stenson M.J., Melhem M.F., Novak A.J., Ansell S.M., and Witzig T.E. Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 105 (2005) 3722-3730
40. Ikeda K., Ogawa S., Tsukui T., Horie-Inoue K., Ouchi Y., Kato S., Muramatsu M., and Inoue S. Protein phosphatase 5 is a negative regulator of estrogen receptor-mediated transcription. Mol. Endocrinol. 18 (2004) 1131-1143
41. Bean L.J., and Stark G.R. Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV. Oncogene 20 (2001) 1076-1084
42. Ryan K.M., Phillips A.C., and Vousden K.H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13 (2001) 332-337
43. Fernandes N., Sun Y., Chen S., Paul P., Shaw R.J., Cantley L.C., and Price B.D. DNA damage-induced association of ATM with its target proteins requires a protein interaction domain in the N terminus of ATM. J. Biol. Chem. 280 (2005) 15158-15164
44. Machino T., Hashimoto S., Maruoka S., Gon Y., Hayashi S., Mizumura K., Nishitoh H., Ichijo H., and Horie T. Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates hydrogen peroxide-induced apoptosis in human pulmonary vascular endothelial cells. Crit. Care Med. 31 (2003) 2776-2781
45. Huang S., Shu L., Easton J., Harwood F.C., Germain G.S., Ichijo H., and Houghton P.J. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity. J. Biol. Chem. 279 (2004) 36490-36496
46. Huang S., Shu L., Dilling M.B., Easton J., Harwood F.C., Ichijo H., and Houghton P.J. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol. Cell 11 (2003) 1491-1501